BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16086224)

  • 1. Gastrointestinal involvement of posttransplant lymphoproliferative disorder in lung transplant recipients: report of a case.
    Shitrit D; Shitrit AB; Dickman R; Sahar G; Saute M; Kramer MR
    Dis Colon Rectum; 2005 Nov; 48(11):2144-7. PubMed ID: 16086224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression.
    Armitage JM; Kormos RL; Stuart RS; Fricker FJ; Griffith BP; Nalesnik M; Hardesty RL; Dummer JS
    J Heart Lung Transplant; 1991; 10(6):877-86; discussion 886-7. PubMed ID: 1661607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abdominal-pelvic lymphoproliferative disease after lung transplantation: presentation and outcome.
    Hachem RR; Chakinala MM; Yusen RD; Lynch JP; Aloush AA; Patterson GA; Trulock EP
    Transplantation; 2004 Feb; 77(3):431-7. PubMed ID: 14966421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
    Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
    Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC; Curtis JL; Szmuszkovicz JR; Horn MV; Ford HR; Woo MS; Wang KS
    J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
    Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplant lymphoproliferative disorders in lung transplant recipients: clinical experience at a single center.
    Angel LF; Cai TH; Sako EY; Levine SM
    Ann Transplant; 2000; 5(3):26-30. PubMed ID: 11147026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
    Bakker NA; Verschuuren EA; Erasmus ME; Hepkema BG; Veeger NJ; Kallenberg CG; van der Bij W
    Transplantation; 2007 Feb; 83(4):433-8. PubMed ID: 17318076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients.
    Raj R; Frost AE
    J Heart Lung Transplant; 2005 Jun; 24(6):671-9. PubMed ID: 15949726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization.
    Lones MA; Lopez-Terrada D; Weiss LM; Shintaku IP; Said JW
    Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain tumor as an unusual presentation of posttransplant lymphoproliferative disorder.
    Azarpira N; Torabineghad S; Rakei M
    Exp Clin Transplant; 2009 Mar; 7(1):58-61. PubMed ID: 19364315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttransplant lymphoproliferative disorders in transplant recipients.
    Timurağaoğlu A; Uğur-Bilgin A; Colak D; Tuncer M; Gölbaşi I; Hazar V; Kiliçarsłan B; Undar L; Demirbaş A
    Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttransplant lymphoproliferative disorder with lung involvement in a renal transplant recipient.
    Mirza EI; Mutluay R; Suyani E; Okyay GU; Akyurek N; Aki SZ; Derici U; Arinsoy T
    Exp Clin Transplant; 2011 Dec; 9(6):425-8. PubMed ID: 22142053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
    Gong JZ; Bayerl MG; Sandhaus LM; Sebastian S; Rehder CW; Routbort M; Lagoo AS; Szabolcs P; Chiu J; Comito M; Buckley PJ
    Am J Surg Pathol; 2006 Mar; 30(3):328-36. PubMed ID: 16538052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chorioretinal lymphoproliferative disorder induced by Epstein-Barr virus in lung transplantation].
    Demols P; Caspers-Velu L; Velu T; Verougstraete C; Zanen A
    Bull Soc Belge Ophtalmol; 1995; 259():109-13. PubMed ID: 8983528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Otolaryngological manifestations of posttransplant lymphoproliferative disorder in pediatric thoracic transplant patients.
    Herrmann BW; Sweet SC; Hayashi RJ; Canter CE; White FV; Lieu JE
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):303-10. PubMed ID: 16125255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttransplant Lymphoproliferative Disorder Manifesting as Intestinal Epstein-Barr Virus-Positive Anaplastic Large-Cell Lymphoma in an Adult Renal Transplant Recipient.
    Börcek P; Özdemir BH; Özgün G; Haberal M
    Exp Clin Transplant; 2016 Nov; 14(Suppl 3):64-66. PubMed ID: 27805515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F
    Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission.
    Knoop C; Kentos A; Remmelink M; Garbar C; Goldman S; Feremans W; Estenne M
    Clin Transplant; 2006; 20(2):179-87. PubMed ID: 16640524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.